Neurotoxicity of pesticides: Its relationship with neurodegenerative diseases;Neurotoxicité des pesticides Quel impact sur les maladies neurodégénératives ?

Medecine/Sciences

Volumn 29, Issue 3, 2013, Pages 273-278

  Thany, Steeve H ^a   Reynier, Pascal ^b   Lenaers, Guy ^c  

^a UNIVERSITÉ D'ANGERS   (France)

^b UNIVERSITÉ D'ANGERS   (France)

^c Montpellier University Medical Center   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; INSECTICIDE; PARAQUAT; PESTICIDE; ROTENONE;

ALZHEIMER DISEASE; ANIMAL; CHEMICALLY INDUCED DISORDER; DEGENERATIVE DISEASE; DRUG EFFECT; GENETIC PREDISPOSITION; GENETICS; HUMAN; METABOLISM; MITOCHONDRION; PARKINSON DISEASE; REVIEW;

ALPHA-SYNUCLEIN; ALZHEIMER DISEASE; ANIMALS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INSECTICIDES; MITOCHONDRIA; NEURODEGENERATIVE DISEASES; PARAQUAT; PARKINSON DISEASE; PARKINSON DISEASE, SECONDARY; PESTICIDES; ROTENONE;

EID: 84875667041     PISSN: 07670974     EISSN: 19585381     Source Type: Journal    
DOI: 10.1051/medsci/2013293013     Document Type: Review

References (34)

1. Corrigan FM, Murray L, Wyatt CL, Shore RF. Diorthosubstituted polychlorinated biphenyls in caudate nucleus in Parkinson's disease. Exp Neurol 1998 ; 150 : 339-42.
2. Corrigan FM, Wienburg CL, Shore RF, et al. Organochlorine insecticides in substantia nigra in Parkinson's disease. J Toxicol Environ Health A 2000 ; 59 : 229-34.
3. Lush MJ, Li Y, Read DJ, et al. Neuropathy target esterase and a homologous Drosophila neurodegeneration-associated mutant protein contain a novel domain conserved from bacteria to man. Biochem J 1998 ; 332 : 1-4.
4. Sanchez-Santed F, Canadas F, Flores P, et al. Long-term functional neurotoxicity of paraoxon and chlorpyrifos oxon: behavioral and pharmacological evidence. Neurotoxicol Teratol 2004 ; 26 : 304-17.
5. Lotti M, Moretto A. Organophosphate-induced delayed polyneuropathy. Toxicol Rev 2005 ; 24 : 37-49.
6. Kamel F, Rowland AS, Park LP, et al. Neurobehavioral performance and work experience in Florida farmworkers. Environ Health Perspect 2003 ; 111 : 1765-72.
7. Starks SE, Hoppin JA, Kamel F, et al. Peripheral nervous system function and organophosphate pesticide use among licensed pesticide applicators in the Agricultural Health Study. Environ Health Perspect 2012 ; 120 : 515-20.
8. Sherer TB, Kim JH, Betarbet R, Greenamyre JT. Subcutaneous rotenone exposure causes highly selective dopaminergic degeneration and alpha-synuclein aggregation. Exp Neurol 2003 ; 179 : 9-16.
9. Hoglinger GU, Oertel WH, Hirsch EC. The rotenone model of parkinsonism-the five years inspection. J Neural Transm Suppl 2006 ; (70) : 269-72.
10. Chaves RS, Melo TQ, Martins SA, Ferrari MF. Protein aggregation containing beta-amyloid, alphasynuclein and hyperphosphorylated tau in cultured cells of hippocampus, substantia nigra and locus coeruleus after rotenone exposure. BMC Neurosci 2010; 11: 144.
11. Hoglinger GU, Feger J, Prigent A, et al. Chronic systemic complex I inhibition induces a hypokinetic multisystem degeneration in rats. J Neurochem 2003 ; 84 : 491-502.
12. McCormack AL, Di Monte DA. Effects of L-dopa and other amino acids against paraquat-induced nigrostriatal degeneration. J Neurochem 2003 ; 85 : 82-6.
13. Purisai MG, McCormack AL, Cumine S, et al. Microglial activation as a priming event leading to paraquat-induced dopaminergic cell degeneration. Neurobiol Dis 2007 ; 25 : 392-400.
14. Peng J, Stevenson FF, Oo ML, Andersen JK. Iron-enhanced paraquat-mediated dopaminergic cell death due to increased oxidative stress as a consequence of microglial activation. Free Radic Biol Med 2009 ; 46 : 312-20.
15. Smeyne RJ, Jackson-Lewis V. The MPTP model of Parkinson's disease. Brain Res Mol Brain Res 2005 ; 134 : 57-66.
16. Richardson JR, Quan Y, Sherer TB, et al. Paraquat neurotoxicity is distinct from that of MPTP and rotenone. Toxicol Sci 2005 ; 88 : 193-201.
17. Ramachandiran S, Hansen JM, Jones DP, et al. Divergent mechanisms of paraquat, MPP+, and rotenone toxicity: oxidation of thioredoxin and caspase-3 activation. Toxicol Sci 2007 ; 95 : 163-71.
18. Castello PR, Drechsel DA, Patel M. Mitochondria are a major source of paraquat-induced reactive oxygen species production in the brain. J Biol Chem 2007 ; 282 : 14186-93.
19. Drechsel DA, Patel M. Differential contribution of the mitochondrial respiratory chain complexes to reactive oxygen species production by redox cycling agents implicated in parkinsonism. Toxicol Sci 2009 ; 112 : 427-34.
20. Zhang Y, Dawson VL, Dawson TM. Oxidative stress and genetics in the pathogenesis of Parkinson's disease. Neurobiol Dis 2000 ; 7 : 240-50.
21. Sherer TB, Richardson JR, Testa CM, et al. Mechanism of toxicity of pesticides acting at complex I: relevance to environmental etiologies of Parkinson's disease. J Neurochem 2007 ; 100 : 1469-79.
22. Choi WS, Palmiter RD, Xia Z. Loss of mitochondrial complex I activity potentiates dopamine neuron death induced by microtubule dysfunction in a Parkinson's disease model. J Cell Biol 2011 ; 192 : 873-82.
23. Thomas B, Flint B. Molecular insights into Parkinson's disease. F1000 Reports Med 2011 ; 3 : 7-15.
24. Kruger R, Kuhn W, Muller T, et al. Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. Nat Genet 1998 ; 18 : 106-8.
25. Polymeropoulos MH, Lavedan C, Leroy E, et al. Mutation in the alphasynuclein gene identified in families with Parkinson's disease. Science 1997 ; 276 : 2045-7.
26. Zarranz JJ, Alegre J, Gomez-Esteban JC, et al. The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia. Ann Neurol 2004 ; 55 : 164-73.
27. Diaz-Corrales FJ, Asanuma M, Miyazaki I, et al. Rotenone induces aggregation of gamma-tubulin protein and subsequent disorganization of the centrosome: relevance to formation of inclusion bodies and neurodegeneration. Neuroscience 2005 ; 133 : 117-35.
28. Casarejos MJ, Menendez J, Solano RM, et al. Susceptibility to rotenone is increased in neurons from parkin null mice and is reduced by minocycline. J Neurochem 2006 ; 97 : 934-46.
29. Kwon HJ, Heo JY, Shim JH, et al. DJ-1 mediates paraquat-induced dopaminergic neuronal cell death. Toxicol Lett 2011 ; 202 : 85-92.
30. Costa LG. Current issues in organophosphate toxicology. Clin Chim Acta 2006 ; 366 : 1-13.
31. Tsatsakis AM, Zafiropoulos A, Tzatzarakis MN, et al. Relation of PON1 and CYP1A1 genetic polymorphisms to clinical findings in a cross-sectional study of a Greek rural population professionally exposed to pesticides. Toxicol Lett 2009 ; 186 : 66-72.
32. Zintzaras E, Hadjigeorgiou GM. Association of paraoxonase 1 gene polymorphisms with risk of Parkinson's disease: a meta-analysis. J Hum Genet 2004 ; 49 : 474-81.
33. Manthripragada AD, Costello S, Cockburn MG, et al. Paraoxonase 1, agricultural organophosphate exposure, and Parkinson disease. Epidemiology 2010 ; 21 : 87-94.
34. Draganov DI, Teiber JF, Speelman A, et al. Human paraoxonases (PON1, PON2, and PON3) are lactonases with overlapping and distinct substrate specificities. J Lipid Res 2005 ; 46 : 1239-47.